roteq 2mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - ropinirole hydrochloride - film coated tablets - 2mg - ropinirole hydrochloride (8000002043) 2,28mg - ropinirole
roteq 0.5mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - ropinirole hydrochloride - film coated tablets - 0.5mg - ropinirole hydrochloride (8000002043) 0,57mg - ropinirole
roteq 4mg film coated tablets
delorbis pharmaceuticals ltd - ropinirole hydrochloride - film coated tablets - 4mg - 8000002043 - ropinirole hydrochloride - 4.56 mg - ropinirole
tripan 20mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - tadalafil - film coated tablets - 20mg - tadalafil (8000001855) 20mg - tadalafil
apredonav 5mg film coated tablets
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - ivabradine hydrochloride - film coated tablets - 5mg - ivabradine hydrochloride (0148849676) 5,39mg
apredonav 7.5mg film coated tablets
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - ivabradine hydrochloride - film coated tablets - 7.5mg - ivabradine hydrochloride (0148849676) 8,085mg
bivelen 7.5mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - ivabradine oxalate - film coated tablets - 7.5mg - ivabradine oxalate (0134655808) 8,941mg
bivelen 5mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - ivabradine oxalate - film coated tablets - 5mg - ivabradine oxalate (0134655808) 5,961mg
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - Οφθαλμολογικά - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Οφθαλμολογικά - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).